Trial Profile
The Effects of Risperdal Consta on Health Care Utilization Costs in Chronically Ill Schizophrenic Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2010
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 06 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Nov 2006 New trial record.